These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 30139748)

  • 1. Biological scaffold-mediated delivery of myostatin inhibitor promotes a regenerative immune response in an animal model of Duchenne muscular dystrophy.
    Estrellas KM; Chung L; Cheu LA; Sadtler K; Majumdar S; Mula J; Wolf MT; Elisseeff JH; Wagner KR
    J Biol Chem; 2018 Oct; 293(40):15594-15605. PubMed ID: 30139748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression rate of myogenic regulatory factors and muscle growth factor after botulinum toxin A injection in the right masseter muscle of dystrophin deficient (mdx) mice.
    Botzenhart UU; Gerlach R; Gredes T; Rentzsch I; Gedrange T; Kunert-Keil C
    Adv Clin Exp Med; 2019 Jan; 28(1):11-18. PubMed ID: 30085421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.
    St Andre M; Johnson M; Bansal PN; Wellen J; Robertson A; Opsahl A; Burch PM; Bialek P; Morris C; Owens J
    Skelet Muscle; 2017 Nov; 7(1):25. PubMed ID: 29121992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.
    Jin Q; Qiao C; Li J; Xiao B; Li J; Xiao X
    Skelet Muscle; 2019 May; 9(1):16. PubMed ID: 31133057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
    Fakhfakh R; Michaud A; Tremblay JP
    Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy.
    Kemaladewi DU; Hoogaars WM; van Heiningen SH; Terlouw S; de Gorter DJ; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; ten Dijke P; 't Hoen PA
    BMC Med Genomics; 2011 Apr; 4():36. PubMed ID: 21507246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy.
    Fontelonga TM; Jordan B; Nunes AM; Barraza-Flores P; Bolden N; Wuebbles RD; Griner LM; Hu X; Ferrer M; Marugan J; Southall N; Burkin DJ
    Hum Mol Genet; 2019 Jul; 28(13):2120-2132. PubMed ID: 30806670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved success of myoblast transplantation in mdx mice by blocking the myostatin signal.
    Benabdallah BF; Bouchentouf M; Tremblay JP
    Transplantation; 2005 Jun; 79(12):1696-702. PubMed ID: 15973171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergent impact of Toll-like receptor 2 deficiency on repair mechanisms in healthy muscle versus Duchenne muscular dystrophy.
    Mojumdar K; Giordano C; Lemaire C; Liang F; Divangahi M; Qureshi ST; Petrof BJ
    J Pathol; 2016 May; 239(1):10-22. PubMed ID: 26800321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myostatin genetic inactivation inhibits myogenesis by muscle-derived stem cells in vitro but not when implanted in the mdx mouse muscle.
    Tsao J; Vernet DA; Gelfand R; Kovanecz I; Nolazco G; Bruhn KW; Gonzalez-Cadavid NF
    Stem Cell Res Ther; 2013 Jan; 4(1):4. PubMed ID: 23295128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.
    Wehling-Henricks M; Sokolow S; Lee JJ; Myung KH; Villalta SA; Tidball JG
    Hum Mol Genet; 2008 Aug; 17(15):2280-92. PubMed ID: 18430716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
    Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
    Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression patterns of regulatory RNAs, including lncRNAs and tRNAs, during postnatal growth of normal and dystrophic (mdx) mouse muscles, and their response to taurine treatment.
    Butchart LC; Terrill JR; Rossetti G; White R; Filipovska A; Grounds MD
    Int J Biochem Cell Biol; 2018 Jun; 99():52-63. PubMed ID: 29578051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation of α7 nicotinic acetylcholine receptor (nAChRα7) inhibits muscular degeneration in mdx dystrophic mice.
    Leite PE; Gandía L; de Pascual R; Nanclares C; Colmena I; Santos WC; Lagrota-Candido J; Quirico-Santos T
    Brain Res; 2014 Jul; 1573():27-36. PubMed ID: 24833065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-146a deficiency does not aggravate muscular dystrophy in mdx mice.
    Bronisz-Budzyńska I; Chwalenia K; Mucha O; Podkalicka P; Karolina-Bukowska-Strakova ; Józkowicz A; Łoboda A; Kozakowska M; Dulak J
    Skelet Muscle; 2019 Aug; 9(1):22. PubMed ID: 31412923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice.
    Qiao C; Li J; Jiang J; Zhu X; Wang B; Li J; Xiao X
    Hum Gene Ther; 2008 Mar; 19(3):241-54. PubMed ID: 18288893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of exosome-mediated delivery of myostatin propeptide on functional recovery of mdx mice.
    Ran N; Gao X; Dong X; Li J; Lin C; Geng M; Yin H
    Biomaterials; 2020 Apr; 236():119826. PubMed ID: 32028167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X Axis.
    Gazzerro E; Baldassari S; Assereto S; Fruscione F; Pistorio A; Panicucci C; Volpi S; Perruzza L; Fiorillo C; Minetti C; Traggiai E; Grassi F; Bruno C
    Am J Pathol; 2015 Dec; 185(12):3349-60. PubMed ID: 26465071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of myostatin and follistatin in Mdx mice, an animal model for muscular dystrophy.
    Abe S; Soejima M; Iwanuma O; Saka H; Matsunaga S; Sakiyama K; Ide Y
    Zoolog Sci; 2009 May; 26(5):315-20. PubMed ID: 19715499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.